Bayer Consumer Health Journey Still Short Of Destination
This article was originally published in The Pink Sheet
Executive Summary
Bayer says issues encountered after acquiring Merck & Co.’s consumer brands two years ago have meant slower growth than expected. But it suggests that’s not a precedent for its planned mega-merger with Monsanto.